Healius Ltd (ASX:HLS)’s stock price shot up 1.9% during mid-day trading on Friday . The company traded as high as A$3.29 ($2.33) and last traded at A$3.27 ($2.32), 1,477,953 shares changed hands during mid-day trading. The stock had previously closed at A$3.21 ($2.28).

The stock has a fifty day moving average price of A$2.96 and a 200-day moving average price of A$2.96. The firm has a market capitalization of $2.03 billion and a PE ratio of 35.54. The company has a debt-to-equity ratio of 39.90, a quick ratio of 0.78 and a current ratio of 0.88.

The business also recently declared a Final dividend, which will be paid on Friday, September 27th. Stockholders of record on Friday, September 27th will be issued a $0.034 dividend. The ex-dividend date of this dividend is Thursday, August 29th. This represents a dividend yield of 1.13%. Healius’s dividend payout ratio is presently 76.09%.

In related news, insider Robert Hubbard purchased 25,000 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were acquired at an average cost of A$3.09 ($2.19) per share, for a total transaction of A$77,150.00 ($54,716.31).

About Healius (ASX:HLS)

Healius Limited provides various services and facilities to general practitioners, dentists, physiotherapists, specialists, and other healthcare professionals in Australia. It operates through three segments: Pathology, Medical Centres, and Imaging. The company offers diagnostic imaging services, such as X-ray, ultrasound, computerized tomography, mammography, MRI, positron emission tomography, interventional radiology, and nuclear medicine services; and medical laboratory and pathology services.

Recommended Story: How is inflation measured?

Receive News & Ratings for Healius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healius and related companies with MarketBeat.com's FREE daily email newsletter.